Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet Holdings, Inc. Appoints Richard J. Heppenstall as Chief Financial Officer

09/14/2021 | 07:00am EDT

Zimmer Biomet Holdings, Inc. announced key appointments to the "NewCo" leadership team, including Richard J. Heppenstall as Executive Vice President and Chief Financial Officer. Additionally, the Company announced ZimVie as the name for the planned spin-off company for the Spine and Dental businesses. Mr. Heppenstall brings more than 25 years of broad corporate and operational finance experience to ZimVie, most recently serving as Chief Financial Officer of Breg, Inc.


ę S&P Capital IQ 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
10/07ZIMMER BIOMET : Announces Webcast and Conference Call of Third Quarter 2021 Financial Resu..
PR
10/05ZIMMER BIOMET : Barclays Cuts Price Target on Zimmer Biomet to $186 From $210, Keeps Overw..
MT
09/29ZIMMER BIOMET HOLDINGS, INC. : Ex-dividend day for
FA
09/28WALL STREET STOCK EXCHANGE : Is inflation still transitionary?
09/28ANALYST RECOMMENDATIONS : 888, Chesapeake Energy, Conocophillips, Marathon Oil, Playtech....
09/27ZIMMER BIOMET : Needham Lowers PT for Zimmer Biomet Holdings to $187 From $202 Given Impac..
MT
09/15ZIMMER BIOMET : Announces Key Additions to 'NewCo' Leadership Team, Transaction to Form Ne..
AQ
09/14ZIMMER BIOMET : Names Finance Chief for Company Spin-Off
MT
09/14ZIMMER BIOMET : Announces Key Additions to "NewCo" Leadership Team; Transaction to Form Ne..
PR
09/14Zimmer Biomet Holdings, Inc. Announces Executive Changes
CI
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 8 061 M - -
Net income 2021 967 M - -
Net Debt 2021 6 377 M - -
P/E ratio 2021 33,2x
Yield 2021 0,64%
Capitalization 31 291 M 31 291 M -
EV / Sales 2021 4,67x
EV / Sales 2022 4,26x
Nbr of Employees 20 000
Free-Float 66,8%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 30
Last Close Price 149,83 $
Average target price 184,67 $
Spread / Average Target 23,3%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-2.76%31 541
ABBOTT LABORATORIES17.02%224 403
MEDTRONIC PLC5.90%166 288
BECTON, DICKINSON AND COMPANY-1.55%70 767
HOYA CORPORATION21.09%55 682
DEXCOM, INC.52.99%54 986